Xebio Holdings Co., Ltd. (TYO:8281)
1,039.00
-5.00 (-0.48%)
May 26, 2026, 3:30 PM JST
Xebio Holdings Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 15,808 | 19,855 | 24,941 | 32,890 | 39,893 |
Cash & Short-Term Investments | 15,808 | 19,855 | 24,941 | 32,890 | 39,893 |
Cash Growth | -20.38% | -20.39% | -24.17% | -17.55% | -9.99% |
Accounts Receivable | 16,654 | 20,662 | 22,994 | 23,854 | 23,152 |
Other Receivables | 662 | 54 | 239 | 157 | 1 |
Receivables | 17,316 | 20,716 | 23,233 | 24,011 | 23,153 |
Inventory | 87,543 | 81,540 | 82,943 | 80,714 | 75,921 |
Other Current Assets | 12,833 | 8,616 | 8,852 | 8,190 | 8,045 |
Total Current Assets | 133,500 | 130,727 | 139,969 | 145,805 | 147,012 |
Property, Plant & Equipment | 36,206 | 39,310 | 36,539 | 35,385 | 31,891 |
Long-Term Investments | 22,428 | 21,358 | 21,020 | 18,739 | 19,032 |
Goodwill | 83 | 24 | 44 | 330 | 716 |
Other Intangible Assets | 9,128 | 8,701 | 8,159 | 6,454 | 4,779 |
Long-Term Deferred Tax Assets | 4,650 | 3,838 | 3,792 | 4,574 | 4,852 |
Other Long-Term Assets | 1 | 1 | 1 | 1 | 2 |
Total Assets | 205,996 | 203,959 | 209,530 | 211,300 | 208,308 |
Accounts Payable | 52,383 | 46,392 | 50,501 | 52,461 | 50,487 |
Accrued Expenses | 1,216 | 1,268 | 1,334 | 1,314 | 1,485 |
Short-Term Debt | 900 | 500 | 700 | 800 | 770 |
Current Portion of Long-Term Debt | 185 | 967 | 1,838 | 1,840 | 5,953 |
Current Income Taxes Payable | 1,106 | 2,188 | 547 | 1,521 | 1,808 |
Other Current Liabilities | 17,305 | 15,253 | 15,639 | 14,241 | 14,181 |
Total Current Liabilities | 73,095 | 66,568 | 70,559 | 72,177 | 74,684 |
Long-Term Debt | 1,799 | 1,982 | 2,936 | 4,772 | 6,459 |
Long-Term Leases | 3,402 | 3,917 | 4,479 | 5,222 | 2,001 |
Pension & Post-Retirement Benefits | 831 | 829 | 901 | 921 | 964 |
Other Long-Term Liabilities | 8,557 | 8,533 | 5,844 | 5,641 | 5,494 |
Total Liabilities | 87,684 | 81,829 | 84,719 | 88,733 | 89,602 |
Common Stock | 15,935 | 15,935 | 15,935 | 15,935 | 15,935 |
Additional Paid-In Capital | 16,103 | 16,106 | 16,119 | 16,119 | 16,119 |
Retained Earnings | 93,811 | 97,427 | 97,765 | 96,499 | 92,427 |
Treasury Stock | -9,774 | -9,511 | -6,498 | -6,498 | -6,498 |
Comprehensive Income & Other | 2,083 | 1,762 | 1,129 | 310 | 681 |
Total Common Equity | 118,158 | 121,719 | 124,450 | 122,365 | 118,664 |
Minority Interest | 154 | 411 | 361 | 202 | 42 |
Shareholders' Equity | 118,312 | 122,130 | 124,811 | 122,567 | 118,706 |
Total Liabilities & Equity | 205,996 | 203,959 | 209,530 | 211,300 | 208,308 |
Total Debt | 6,286 | 7,366 | 9,953 | 12,634 | 15,183 |
Net Cash (Debt) | 9,522 | 12,489 | 14,988 | 20,256 | 24,710 |
Net Cash Growth | -23.76% | -16.67% | -26.01% | -18.02% | -14.47% |
Net Cash Per Share | 230.00 | 288.68 | 337.23 | 456.27 | 556.82 |
Filing Date Shares Outstanding | 41.38 | 41.38 | 43.97 | 44.21 | 44.21 |
Total Common Shares Outstanding | 41.38 | 41.6 | 44.21 | 44.21 | 44.21 |
Working Capital | 60,405 | 64,159 | 69,410 | 73,628 | 72,328 |
Book Value Per Share | 2855.18 | 2926.14 | 2814.93 | 2767.77 | 2684.04 |
Tangible Book Value | 108,947 | 112,994 | 116,247 | 115,581 | 113,169 |
Tangible Book Value Per Share | 2632.60 | 2716.39 | 2629.39 | 2614.32 | 2559.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.